Stockscreener 앱 받기
2.92
0.69%
0.02
시간 외 거래:
2.92
전일 마감가:
$2.90
열려 있는:
$2.925
하루 거래량:
21,624
Relative Volume:
1.12
시가총액:
$48.96M
수익:
$1.02M
순이익/손실:
$-36.14M
주가수익비율:
-0.2843
EPS:
-10.27
순현금흐름:
$-18.50M
1주 성능:
-5.81%
1개월 성능:
+1.04%
6개월 성능:
+9.77%
1년 성능:
+14.96%
1일 변동 폭
$2.85
$2.96
1주일 범위
$2.85
$3.08
52주 변동 폭
$2.08
$4.34
OncoCyte Corporation Stock (OCX) Company Profile
명칭
OncoCyte Corporation
전화
510-775-0515
주소
1010 Atlantic Avenue, Suite 102, Alameda, CA
OncoCyte Corporation Stock (OCX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-24 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-03-17 | 재개 | Needham | Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | 개시 | BTIG Research | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | 재확인 | The Benchmark Company | Speculative Buy |
| 2020-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | 개시 | Needham | Buy |
| 2019-02-13 | 개시 | Piper Jaffray | Overweight |
| 2019-01-29 | 업그레이드 | Janney | Neutral → Buy |
| 2018-12-19 | 재개 | Lake Street | Buy |
모두보기
OncoCyte Corporation 주식(OCX)의 최신 뉴스
OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) - MarketBeat
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - The Manila Times
Oncocyte Corp expands equity incentive plan - Investing.com India
Oncocyte Corp expands equity incentive plan By Investing.com - Investing.com Australia
OncoCyte shares maintain Buy rating from Needham By Investing.com - Investing.com Nigeria
OncoCyte shares maintain Buy rating from Needham - Investing.com
OncoCyte Corp (OCX) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - Yahoo Finance
Oncocyte reports breakthrough in breast cancer diagnostics - Investing.com
Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - The Manila Times
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - StockTitan
Broadwood Partners L.P. buys Oncocyte shares for $3.88 million By Investing.com - Investing.com Australia
Oncocyte CFO acquires $99,999 worth of company shares By Investing.com - Investing.com South Africa
Oncocyte CFO acquires $99,999 worth of company shares - Investing.com
Broadwood Partners L.P. buys Oncocyte shares for $3.88 million - Investing.com
OncoCyte Secures Funding Through Private Share Sale - Yahoo Finance
OncoCyte Corporation announced that it expects to receive $10.203435 million in funding from Bio-Rad Laboratories, Inc. - Marketscreener.com
LENSAR reports inducement grants - Medical Buyer
Oncocyte Corporation enters into securities purchase agreement - Medical Buyer
Oncocyte Signs Leading Transplant Centers in US and Germany - The Manila Times
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules - ForexTV.com
Sandfire Resources America Inc. Announces Incentive Plan Grants - The Manila Times
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Breast Biopsy Devices Market 2024 – Industry Scenario, Strategies, Growth Factors and Forecast 2032 | OncoCyte Corporation, Benetec - 대구포스트
Breast Cancer Predictive Genetic Testing Market 2024 Key Stakeholders, CAGR, Growth Factors and Forecast 2032 | OncoCyte Corporation, Myriad Genetics - 대구포스트
OncoCyte Corporation announced that it has received $10.203435 million in funding from Bio-Rad Laboratories, Inc. - Marketscreener.com
Raymond James Equities Analysts Increase Earnings Estimates for OceanaGold Co. (TSE:OGC) - MarketBeat
Orion (NYSE:OEC) Raised to “Buy” at StockNews.com - Defense World
Recent Insider Activity Suggests Potential Gains for Outset Medical Inc (OM) - Knox Daily
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Oscar Health Inc [OSCR] Investment Guide: What You Need to Know - Knox Daily
16,619 Shares in Owens Corning (NYSE:OC) Bought by Point72 DIFC Ltd - Defense World
Great Point Partners LLC Invests $15.73 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Market Highlights: Oscar Health Inc (OSCR) Ends on a Low Note at 22.33 - The Dwinnex
OM Stock on the Rise: A Promising Investment - The InvestChronicle
Was Outset Medical Inc (OM)’s session last reading good? - US Post News
Ondine Biomedical secures CAD5 million financing - Marketscreener.com
30,143 Shares in Oshkosh Co. (NYSE:OSK) Acquired by Magnetar Financial LLC - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Views of Wall Street’s Leading Experts on Onconetix Inc - SETE News
Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Summit Trail Advisors LLC - Defense World
Ratio Review: Analyzing Ocugen Inc (OCGN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
First Light Asset Management LLC Sells 236,632 Shares of Oscar Health, Inc. (NYSE:OSCR) - MarketBeat
Financial Metrics Unveiled: Outset Medical Inc (OM)’s Key Ratios in the Spotlight - The Dwinnex
Onto Innovation Inc. (NYSE:ONTO) Shares Sold by Epoch Investment Partners Inc. - Defense World
Outset Medical, Inc. (NASDAQ:OM) Might Not Be As Mispriced As It Looks After Plunging 27% - Simply Wall St
ONWARD Medical lists on Euronext Paris - Euronext
American Century Companies Inc. Grows Stake in Osisko Gold Royalties Ltd (NYSE:OR) - MarketBeat
Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews.com - Defense World
O-I Glass Inc (OI) Becoming More Attractive for Investors - Knox Daily
Owens Corning exec sells over $538k in company stock By Investing.com - Investing.com UK
OncoCyte Corporation (OCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):